Carthera

Paris, France Founded: 2010 • Age: 16 yrs
Ultrasound-based medical devices for brain tumor treatment are developed.

About Carthera

Carthera is a company based in Paris (France) founded in 2010. It operates as a HealthTech. Carthera has raised $55.06 million across 5 funding rounds from investors including Bpifrance, European Union and Unorthodox Ventures. Carthera offers products and services including SonoCloud. Carthera operates in a competitive market with competitors including Insightec, HistoSonics, Profound Medical, Theraclion and SONIRE Therapeutics, among others.

  • Headquarter Paris, France
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Carthera Incorporated
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $55.06 M (USD)

    in 5 rounds

  • Latest Funding Round
    $4.84 M (USD), Series B

    Dec 11, 2023

  • Investors
    Bpifrance

    & 9 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Carthera

Carthera offers a comprehensive portfolio of products and services, including SonoCloud. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Ultrasound device opens blood-brain barrier for therapy.

People of Carthera
Headcount 1-10
Employee Profiles 7
Board Members and Advisors 9
Employee Profiles
People
Frederic Sottilini
CEO
People
Carole Desseaux
Head Of Clinical Affairs
People
Michael Canney
Chief Scientific Officer
People
Audrey Chanoinat
CFO Part-time

Unlock access to complete

Board Members and Advisors
people
Diana Saraceni
Director
people
Alexis De Longevialle
Advisor
people
Celia Hart
Director
people
Alexandre Carpentier
Advisor

Unlock access to complete

Funding Insights of Carthera

Carthera has successfully raised a total of $55.06M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $4.84 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Series B — $4.8M
  • First Round

    (13 Oct 2016)

  • Investors Count 10
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2023 Amount Series B - Carthera Valuation Unorthodox Ventures
Jun, 2023 Amount Series B - Carthera Valuation Relyens , EIC Fund
Oct, 2020 Amount Grant - Carthera Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Carthera

Carthera has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Bpifrance, European Union and Unorthodox Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage investments are made in medical and construction technology.
Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Carthera

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Carthera

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Carthera Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Carthera

Carthera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insightec, HistoSonics, Profound Medical, Theraclion and SONIRE Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
MR-interfaced ultrasound devices for cancer and neurology treatments are provided.
domain founded_year HQ Location
Tissue ablation is achieved through non-invasive ultrasound Histotripsy technology.
domain founded_year HQ Location
Image-guided prostate ablation systems for cancer treatment are developed.
domain founded_year HQ Location
Provider of non-invasive robotic ultrasound therapy devices
domain founded_year HQ Location
High-intensity focused ultrasound systems for targeted cancer treatments are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Carthera

Frequently Asked Questions about Carthera

When was Carthera founded?

Carthera was founded in 2010 and raised its 1st funding round 6 years after it was founded.

Where is Carthera located?

Carthera is headquartered in Paris, France.

Is Carthera a funded company?

Carthera is a funded company, having raised a total of $55.06M across 5 funding rounds to date. The company's 1st funding round was a Grant of $2.42M, raised on Oct 13, 2016.

What does Carthera do?

Carthera is engaged in the development of innovative ultrasound-based medical devices aimed at treating severe brain disorders. The companys primary focus is on oncology indications such as glioblastoma and brain metastases, while also exploring solutions for neurodegenerative conditions like Alzheimers Disease. Their flagship product, SonoCloud, is designed to temporarily open the blood-brain barrier using low-intensity pulsed ultrasound, enhancing the delivery of therapeutic agents like chemotherapy and immunotherapy to the brain. Clinical trials are being conducted to validate the efficacy and safety of this technology across multiple international locations. Carthera collaborates with pharmaceutical partners to address high unmet medical needs in brain tumor treatments and other central nervous system diseases.

Who are the top competitors of Carthera?

Carthera's top competitors include Insightec, HistoSonics and Profound Medical.

What products or services does Carthera offer?

Carthera offers SonoCloud.

Who are Carthera's investors?

Carthera has 10 investors. Key investors include Bpifrance, European Union, Unorthodox Ventures, Supernova Invest, and Heritiers Saint-Genys.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available